Clinical Trial Update: Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating lapatinib in combination with oral vinorelbine for metastatic breast cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED